How to Inject Tirzepatide: Step-by-Step for Mounjaro and Zepbound Pens and Vials

How to inject tirzepatide depends on your device, not your brand. Mounjaro and Zepbound are the same medicine, tirzepatide, and each comes as a single-dose pen, a single-dose vial, a multi-dose vial, and a KwikPen [1][7]. The Instructions for Use for each device are word for word the same for both brands, apart from the name [3][9].

This guide turns those instructions into short steps you can follow with one hand free. You will learn:

• The exact steps for the pen, the vial and syringe, and the KwikPen
• How you know the dose went in, device by device
• What to do if something goes wrong, and what not to do after a shot

Every step comes from the FDA label and the 2026 Instructions for Use, not from forums.

Table of Contents

• How to inject tirzepatide: the short answer
• Before your first tirzepatide injection: a checklist
• How to inject tirzepatide with the single-dose pen
• How to inject tirzepatide from a vial with a syringe
• Tirzepatide multi-dose vial: what changes
• Tirzepatide KwikPen: the steps in brief
• Pen vs vial vs KwikPen: how you know the dose is done
• Where to inject tirzepatide
• When to inject tirzepatide: time of day and missed doses
• Tirzepatide injection troubleshooting: if something goes wrong
• What not to do after injecting tirzepatide
• Tirzepatide injection myths vs the label
• How to inject Mounjaro: extra label notes
• Compounded and research tirzepatide: FDA warnings
• Eating well around your tirzepatide injection day
• Key takeaways
• Frequently asked questions

How to Inject Tirzepatide: The Short Answer

To inject tirzepatide, you give one shot under the skin once a week in your stomach or thigh, or a helper gives it in the back of your upper arm [1][7]. The steps change by device, and the label says you should be trained on the exact device you receive [1][7].

Find your device below and jump to its steps:

• Single-dose pen (one shot, needle built in): remove the cap, place it flat, unlock, press and hold. Go to pen steps.
• Single-dose vial (one 0.5 mL dose): draw it up with a new syringe, such as a 1 mL syringe. Go to vial steps.
• Multi-dose vial (four 0.6 mL doses): same steps as the vial, different volume. Go to multi-dose vial.
• KwikPen (four 0.6 mL doses): new pen needle and priming every week. Go to KwikPen.

Both brands use the same six strengths, 2.5 mg to 15 mg [1][7]. For which dose you take each month, see our tirzepatide dosage chart.

Before Your First Tirzepatide Injection: A Checklist

Before your first tirzepatide injection, check the medicine, gather your supplies, and confirm you were trained on your exact device. The label asks prescribers to train you, and to train you again if your device changes [1][7].

Run through this list every week:

1. Right medicine and dose. Check the label for the name, the strength, and the expiration date [3][4].
2. Clear liquid. The medicine should be clear and colorless to slightly yellow. Do not use it if it is frozen, cloudy, or has particles [1][3].
3. Supplies ready. A pen needs nothing extra. A vial needs a new syringe and needle, an alcohol swab, and gauze [4]. A KwikPen needs a new pen needle and an alcohol swab [6].
4. Sharps container nearby. Use an FDA-cleared sharps container, or a heavy-duty plastic household container with a tight-fitting, puncture-resistant lid [3][17].
5. Clean hands. Every Instructions for Use has you wash your hands before you inject [3][4][6].
6. A site chosen. Stomach or thigh for you; the back of the upper arm only if someone else injects [1].
7. The right day. Keep at least 3 days (72 hours) between two doses [2].

If you have vision problems, the Medication Guide says self-injection is not recommended, so ask your provider about help from a trained person [2].

How to Inject Tirzepatide With the Single-Dose Pen

To inject tirzepatide with the single-dose pen, pull off the gray base cap, place the clear base flat on your skin, unlock it, and press and hold the purple button for up to 10 seconds [3][9]. The dose is done when you hear a second loud click and see the gray plunger.

The pen steps below come from the Mounjaro and Zepbound pen instructions, revised April 2026 [3][9]:

1. Take the pen out of the refrigerator. Leave the gray base cap on until you are ready.
2. Check the pen. Confirm the medicine, dose, and date, and make sure the pen is not damaged.
3. Check the medicine. It should not be frozen or cloudy and should have no particles.
4. Wash your hands.
5. Choose your site. Stomach or thigh, or the back of the upper arm if someone else injects.
6. Pull off the gray base cap. Make sure the pen is locked first. Throw the cap away; do not put it back on, and do not touch the needle.
7. Place the clear base flat against your skin. Then turn the lock ring to unlock.
8. Press and hold the purple button for up to 10 seconds. The first click means the injection started. The second click means it is complete.
9. Keep the pen on your skin until the second loud click. You will know the injection is complete when the gray plunger is visible.
10. Put the used pen in a sharps container right away.

The pen instructions add a few reassurances. Air bubbles in the pen are normal, and so is a drop of liquid on the needle tip after the cap comes off [3]. Holding the button down is not required, but it may help keep the pen steady [3].

How to Inject Tirzepatide From a Vial With a Syringe

To inject tirzepatide from a vial, wipe the rubber stopper, draw exactly 0.5 mL into a new syringe (the label's example is a 1 mL syringe), inject under the skin, and keep the needle in for at least 5 seconds [4][10]. The syringe and needle are not included with the vial, so your provider recommends them [4].

Here is how to inject tirzepatide from a single-dose vial, from the Mounjaro and Zepbound vial instructions revised April 2026 [4][10]:

1. Take the vial out of the refrigerator and check the label, dose, date, and the look of the medicine.
2. Wash your hands with soap and water.
3. Pull off the plastic cap. Do not remove the rubber stopper.
4. Wipe the rubber stopper with an alcohol swab.
5. Unwrap the syringe and the needle. If the needle is separate, twist it onto the syringe until it is tight.
6. Pull off the needle shield.
7. Draw 0.5 mL of air. Hold the syringe needle up and pull the plunger to the 0.5 mL line.
8. Push the needle through the stopper and push the plunger all the way in. This puts air into the vial and makes the liquid easier to draw.
9. Turn the vial and syringe upside down. Keep the needle tip in the liquid and slowly pull the plunger past the 0.5 mL line.
10. Remove bubbles. Tap the syringe gently so bubbles rise, then push the plunger up to the 0.5 mL line.
11. Pull the syringe out of the stopper.
12. Choose your site and insert the needle into your skin, as your provider showed you.
13. Push the plunger to inject. Keep the needle in your skin for at least 5 seconds.
14. Pull the needle out. If you see blood, press with gauze and do not rub.
15. Do not recap the needle. Put the syringe and needle in a sharps container right away.

Throw away an opened single-dose vial after use, even if medicine is left in it [4]. The instructions also say not to mix tirzepatide with any other medicine in the syringe [4].

Always use a new syringe and needle for every dose, which prevents infections and blocked needles [4]. Never share needles or syringes with anyone [4].

Tirzepatide Multi-Dose Vial: What Changes

A tirzepatide multi-dose vial holds 4 weekly doses of 0.6 mL, and you follow the same syringe steps as the single-dose vial with 0.6 mL in place of 0.5 mL [5][11]. You pull the plastic cap off only the first time you use a new vial [11].

Three things change:

• Volume. Draw 0.6 mL of air, pull past the 0.6 mL line, then push back to 0.6 mL [11].
• Ingredients. The multi-dose vial and KwikPen also contain benzyl alcohol, glycerin, and phenol [2][8].
• Time limits. Throw an opened multi-dose vial away after 30 days in total at room temperature, 30 days after first use, or 4 weekly doses, even if medicine is left [1][7].

An unopened multi-dose vial kept in the refrigerator lasts until its expiration date [7]. At room temperature, up to 86°F, throw an unopened vial away after 30 days [1][7]. For storage rules for every device, read does Zepbound need refrigeration.

Tirzepatide KwikPen: The Steps in Brief

The tirzepatide KwikPen holds 4 fixed weekly doses, and each week you attach a new pen needle, prime the pen, dial to the stop, and count slowly to 5 while holding the knob [6][12]. Unlike the single-dose pen, it needs priming before every dose.

In short, from the KwikPen instructions revised January 2026 [6][12]:

1. Wash your hands, pull off the pen cap, and check the pen and medicine.
2. Wipe the red inner seal with an alcohol swab, twist on a new pen needle, then pull off the outer needle shield (keep it) and the inner needle shield.
3. Prime: turn the knob until you hear 2 clicks, hold the needle up and tap so air bubbles rise, push the knob in until it stops, and count slowly to 5, with the needle pointing into the air, not into your body. A drop at the needle tip means the pen is primed.
4. Choose a site: stomach or thigh at least 2 inches from the belly button, or the back of the upper arm if someone else injects.
5. Turn the dose knob all the way until it stops and the dose icon shows. Do not count clicks.
6. Insert the needle, push the knob in until it stops, and count slowly to 5.
7. Check that the 0 icon is in the dose window before you remove the needle.
8. Pull the needle out, put the outer needle shield back on, unscrew the needle into a sharps container, and replace the pen cap.

Never share a KwikPen, even with a new needle, because it can spread blood-borne infections [1][7]. Pen needles, priming problems, and the 4-dose limit are covered in our Zepbound KwikPen guide.

Pen vs Vial vs KwikPen: How You Know the Dose Is Done

Each tirzepatide device has its own done signal: a second click and gray plunger for the pen, at least 5 seconds with the needle in for a vial, and the 0 icon for the KwikPen [3][4][6]. Do not borrow one device's hold time for another.

Sources: Mounjaro and Zepbound Instructions for Use for each device, revised January to April 2026 [3][4][5][6].

Where to Inject Tirzepatide

You can inject tirzepatide under the skin of your stomach or thigh, and another person should inject the back of your upper arm [1][7]. The label says exposure was similar at all three sites, so it gives no reason to prefer one area over another [1][7].

Rotate your injection site every week [1]. The vial instructions add not to inject where the skin has pits, lumps, scars, bruises, or tenderness [4]. For a map of each area and a rotation plan, see our page on Zepbound injection sites, which applies to Mounjaro too.

When to Inject Tirzepatide: Time of Day and Missed Doses

You can inject tirzepatide once weekly at any time of day, with or without meals, according to both labels [1][7]. Pick one day and a time you will remember.

The label sets clear timing rules [1][7]:

• Missed dose: take it as soon as you can within 4 days (96 hours). If more than 4 days have passed, skip it and take the next dose on your usual day.
• Changing your day: allowed, as long as there are at least 3 days (72 hours) between the two doses.
• Never 2 doses within 3 days of each other [2].

After a shot, blood levels peak a median of 24 hours later, with a range of 8 to 72 hours [1]. A steady level is reached after 4 weekly doses [1]. To see what that means for appetite and weight, read how long it takes for Zepbound to start working.

Tirzepatide Injection Troubleshooting: If Something Goes Wrong

If a tirzepatide injection goes wrong, follow your device's instructions and do not start over with a second dose on your own. The pen instructions say to contact the manufacturer when the gray plunger does not show, and the KwikPen instructions say not to repeat the injection [3][6].

If you think you took too much, the Medication Guide says to call your healthcare provider or Poison Help at 1-800-222-1222, or go to the nearest emergency room right away [2]. Nausea, vomiting, and diarrhea are among the most common side effects, as our Zepbound side effects guide explains [1].

What Not to Do After Injecting Tirzepatide

After injecting tirzepatide, do not rub the site, recap a vial needle, reuse any needle, or take another dose within 3 days [2][3][4]. These rules come straight from the label and Instructions for Use.

Avoid these after every shot:

• Do not rub the injection site. Press gently with gauze or a cotton ball if it bleeds [3][4].
• Do not recap a syringe needle. Recapping can cause a needle stick injury [4].
• Do not reuse needles, syringes, or a single-dose pen, and never share any of them or a KwikPen, even with a new needle [1][4][6].
• Do not throw single-dose pens, syringes, or loose needles in household trash. Use a sharps container [3][4][6]. A KwikPen body, once the needle is removed, can go in household trash or a sharps container [6].
• Do not store a KwikPen with the needle on. It can leak, block the needle, or let air in [6].
• Do not inject leftover medicine from a single-dose vial or a used-up KwikPen [4][6].
• Do not take 2 doses within 3 days (72 hours) [2].
• Do not recycle a full sharps container. Follow your community rules, found through the FDA sharps disposal page [3][17].

Tirzepatide Injection Myths vs the Label

Several tirzepatide injection tips online do not match the Instructions for Use. Six common ones are warming the pen, pinching with the pen, wiping the skin as a label step, a set injection angle, a set needle size, and the idea that the stomach absorbs faster [1][3][4].

How to Inject Mounjaro: Extra Label Notes

To inject Mounjaro, follow the same device steps as Zepbound, because the Mounjaro and Zepbound Instructions for Use match word for word [9][10]. The Mounjaro label adds two notes, and one vial rule shared by both brands matters most if you also use insulin [4][7][8][10].

Mounjaro is approved, with diet and exercise, to improve blood sugar control in adults and children 10 and older with type 2 diabetes. It is also approved to lower the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who are at high risk for them [7]. For injecting, three notes matter:

• Insulin: give Mounjaro and insulin as separate injections and never mix them. They can go in the same body area, but not right next to each other [7][8].
• Children and the KwikPen: the Mounjaro KwikPen is not recommended for self-injection by children. An adult caregiver should give a child those injections [7][8].
• Other medicines at the same site: the vial instructions for both brands say not to inject tirzepatide in the same site used for other medicines [4][10].

Do not use Mounjaro and Zepbound together. The Zepbound label says combining it with other tirzepatide products or any GLP-1 medicine is not recommended [1][2]. For how the two brands differ in approval and coverage, see Zepbound vs Mounjaro.

Compounded and Research Tirzepatide: FDA Warnings

Compounded and "research" tirzepatide products are not FDA-approved, and the FDA warns they do not undergo its review for safety, effectiveness, and quality [13]. As of May 31, 2026, the FDA had received more than 730 adverse event reports linked to compounded tirzepatide [13].

The FDA points to syringe and measuring risks with vials:

• In reports on compounded semaglutide vials, patients injected 5 to 20 times more than the intended dose. Most were unfamiliar with measuring a dose with a syringe, and confusion between milliliters, milligrams, and units may have contributed [14].
• The FDA encourages patients to ask their provider or compounder how to measure and give the intended dose of compounded tirzepatide [13].
• For compounded multi-dose vials, the FDA advises discarding the vial within 28 days after first use, even if medicine remains [13].
• The FDA urges consumers not to buy tirzepatide labeled "for research purposes" or "not for human consumption" [13].

This page does not give mixing or units instructions for compounded products. For their legal status and safety record, read our page on compounded tirzepatide.

Eating Well Around Your Tirzepatide Injection Day

Eating well on tirzepatide supports the medicine, and the Zepbound label says to use it with a reduced-calorie diet and more physical activity [1]. A 2025 joint nutrition advisory pairs enough protein with strength training to help protect muscle during GLP-1 weight loss [16].

A simple weekly routine can help:

• Plan protein-based meals for the days around your shot, so a low-appetite day does not become a skipped-meal day.
• Keep portions small and snacks ready, since nausea is among the most common side effects in the trials [1].
• Add strength training at least 3 times a week, as the advisory suggests [16].

See how much protein to eat on a GLP-1 and our GLP-1 meal plan for a sample week. For high-protein recipes sized for a smaller appetite, see our guide.

Key Takeaways

• How to inject tirzepatide depends on the device. Mounjaro and Zepbound share the same four devices and identical instructions [3][9].
• Each device has its own done signal. Pen: second click and gray plunger. Vial: at least 5 seconds with the needle in. KwikPen: the 0 icon [3][4][6].
• Never repeat a dose on your own. If a shot may have failed, follow your Instructions for Use (pen: contact the manufacturer; KwikPen: do not start over), and keep at least 3 days between doses [2][3][6].
• Use a new needle every time and a sharps container for every needle, syringe, and single-dose pen [3][4][6].

Keep your Instructions for Use with your medicine. If you are still unsure how to inject tirzepatide, ask your provider to watch your first injection.

Frequently Asked Questions

Is it better to inject tirzepatide in the morning or at night?

Neither. The Mounjaro and Zepbound labels say to inject once weekly at any time of day, with or without meals, so pick a time you will remember [1][7].

How long does it take for a tirzepatide shot to kick in?

Blood levels peak a median of 24 hours after a shot, with a range of 8 to 72 hours [1]. A steady level is reached after 4 weekly doses [1].

How many mL is 2.5 mg of tirzepatide?

For FDA-approved products, 2.5 mg is 0.5 mL from a single-dose pen or vial and 0.6 mL from a multi-dose vial or KwikPen [1][7]. The volume is the same at every strength, as our dosage chart shows.

Should I pinch my stomach when injecting Mounjaro?

Not with the single-dose pen: its instructions say to place the clear base flat against your skin [9]. With a vial, your healthcare provider should tell you whether to pinch [10].

Do I need to warm the tirzepatide pen before injecting?

No. The pen instructions say it is not necessary to warm the pen to room temperature [3].

Should I clean my skin with alcohol before a tirzepatide shot?

It is not a step in the Mounjaro or Zepbound instructions, which use the alcohol swab on the vial stopper or KwikPen seal [4][6]. General shot guides include it, so follow what your provider taught you [15].

What size syringe do I need for a tirzepatide vial?

The label gives a 1 mL syringe that can measure a 0.5 mL or 0.6 mL dose as the example, with a new syringe and needle every time [1]. Your provider recommends the needle [4].

Can I inject Mounjaro and insulin in the same place?

Give them as separate injections and never mix them, says the Mounjaro label [7]. They can go in the same body area, but not right next to each other [8].

Can I reuse a needle or syringe for tirzepatide?

No. The instructions say to use a new syringe and needle, or a new pen needle, for every injection to prevent infections and blocked needles [4][6].

How do I know my tirzepatide pen worked?

The single-dose pen delivered your dose if the gray plunger is visible after the second loud click [3]. If you do not see it, the instructions say to contact the manufacturer and store the pen safely [3].

References

1. Zepbound (tirzepatide) Prescribing Information, revised 08/2026: Eli Lilly
2. Zepbound Medication Guide, revised 08/2026: Eli Lilly
3. Zepbound Instructions for Use, single-dose pen, revised April 2026: Eli Lilly
4. Zepbound Instructions for Use, single-dose vial, revised April 2026: Eli Lilly
5. Zepbound Instructions for Use, multi-dose vial, revised January 2026: Eli Lilly
6. Zepbound Instructions for Use, single-patient-use KwikPen, revised January 2026: Eli Lilly
7. Mounjaro (tirzepatide) Prescribing Information, revised 08/2026: Eli Lilly
8. Mounjaro Medication Guide, revised August 2026: Eli Lilly
9. Mounjaro Instructions for Use, single-dose pen, revised April 2026: Eli Lilly
10. Mounjaro Instructions for Use, single-dose vial, revised April 2026: Eli Lilly
11. Mounjaro Instructions for Use, multi-dose vial, revised January 2026: Eli Lilly
12. Mounjaro Instructions for Use, single-patient-use KwikPen, revised January 2026: Eli Lilly
13. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, content current as of 09/01/2026: U.S. Food and Drug Administration
14. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, 07/26/2024: U.S. Food and Drug Administration
15. Subcutaneous (SQ) injections, MedlinePlus Medical Encyclopedia, reviewed 10/19/2025: U.S. National Library of Medicine
16. Nutritional priorities to support GLP-1 therapy for obesity: joint advisory from ACLM, ASN, OMA, and TOS, 2025
17. Safely Using Sharps (Needles and Syringes) at Home, at Work and on Travel: U.S. Food and Drug Administration

This article is for education only and is not medical advice. It summarizes the FDA label and the Instructions for Use, and it gives no personalized dosing advice. Talk to your prescriber about your treatment and your dose. Read our full medical disclaimer.